Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 124 participants.
Also called NCT03047772
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 124 participants
- Sponsor
- Registry
-
NCT03047772
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT03047772. Randomized; triple masking; primary purpose treatment. Start 2018-03-06 (anticipated); primary completion 2018-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients
- Acronym
- TEAM-AMI
- Condition
- Myocardial Infarction
- Condition
- Stem Cell Transplantation
- Condition
- Angioplasty, Transluminal, Percutaneous Coronary
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Intensive Atorvastatin
- Intervention (Drug)
- Low dose BMMSC
- Intervention (Drug)
- Middle dose BMMSC
- Intervention (Drug)
- High dose BMMSC
- Intervention (Drug)
- Transplantation
- Lead sponsor
- Yuejin Yang
- Collaborator
- Peking Union Medical College Hospital
- Collaborator
- The First Hospital of Hebei Medical University
- Collaborator
- Zunyi Medical College
Record details
- Record id
cardio:ct-nct03047772- Content hash
df635b02a4b0dc50dd402a750c946b07edffc28698cecd5159ed13a5a3260d33